Ajinomoto Bio-Pharma Services
11040 Roselle St.
San Diego, CA 92121
T: (858) 882-0123
F: (858) 882-0133
E: info@US.AjiBio-Pharma.com
Facebook: www.facebook.com/AjiBioPharma
LinkedIn: www.linkedin.com/company/ajibio-pharma-services/
Twitter: twitter.com/AjiBioPharma
W: www.AjiBio-Pharma.com

COMPANY DESCRIPTION

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, with sites in Belgium, United States, Japan, and India, providing comprehensive process development services, cGMP manufacturing, and drug product fill finish services for small and large molecule APIs and intermediates.

Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including Corynex^® protein expression technology, oligonucleotide synthesis, high potency APIs (HPAPIs), continuous flow manufacturing, and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs.

Ajinomoto Bio-Pharma Services is your trusted manufacturing partner providing a broad range of capabilities, regulatory excellence, and extensive experience, helping you navigate production challenges, providing solutions to your development process, and delivering your new therapies to patients who need it most.

MARKETS SERVED

Our integrated global network for large and small molecule development and manufacturing has sites in Europe, North America, and Asia, providing the infrastructure and local support to meet your drug process development and manufacturing needs.

SERVICES & CAPABILITES

Phase-Appropriate Services: Our complete range of process and analytical development capabilities offer the tools to address your needs, whether it is producing small quantities for early testing or in developing robust, reliable, and scalable processes that will enable a strong commercial advantage.

Broad Range of Capabilities: Over 40 years of CDMO experience providing a range of manufacturing capabilities enables us to deliver the flexibility and guidance to meet different drug product needs from emerging therapeutics to life cycle management.

• Drug product aseptic fill finish
• Small molecule manufacturing
• Large molecule manufacturing
• Oligonucleotide and peptide synthesis

Advanced Technologies: Our services are enhanced by a portfolio of innovative and advanced technologies that enable robust, scalable, cost- and time-efficient processes for large and small molecule manufacturing. We are continuously developing new solutions to improve manufacturing processes.

Regulatory Support: With and impressive and successful track record, we are well positioned to advise you on regulatory strategies and navigate hurdles to achieve your program goals. We provide strong, yet flexible quality management to ensure continued program success.

EXPERIENCE THE POWER TO MAKE

We have the capacity and know-how to manage projects from preclinical stage to commercialization successfully, but what truly differentiates us is our dedication to quality and our commitment to fostering trusted partnerships. We’re looking forward to hearing from you.